---
title: Together4RD position statement on collaboration between European reference
  networks and industry
date: '2023-09-05'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/37670358/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20230906181400&v=2.17.9.post6+86293ac
source: heidelberg[Affiliation]
description: Notwithstanding two decades of policy and legislation in Europe, aimed
  to foster research and development in rare conditions, only 5-6% of rare diseases
  have dedicated treatments. Given with the huge number of conditions classed as rare
  (which is increasing all the time), this equates to major unmet need for patients
  (over 30 million in the EU alone). Worryingly, the pace of Research and Innovation
  in Europe is lagging behind other regions of the world, and a seismic shift in the
  way in ...
disable_comments: true
---
Notwithstanding two decades of policy and legislation in Europe, aimed to foster research and development in rare conditions, only 5-6% of rare diseases have dedicated treatments. Given with the huge number of conditions classed as rare (which is increasing all the time), this equates to major unmet need for patients (over 30 million in the EU alone). Worryingly, the pace of Research and Innovation in Europe is lagging behind other regions of the world, and a seismic shift in the way in ...